Detalhe da pesquisa
1.
Fibroblast Growth Factor Receptors and Ligands in Context of Bevacizumab Response in Ovarian Carcinoma: An Exploratory Analysis of AGO-OVAR11/ICON-7.
Lab Invest
; 104(4): 100321, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38154497
2.
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer.
N Engl J Med
; 385(23): 2123-2131, 2021 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34874631
3.
Hidden in plain sight - Survival consequences of baseline symptom burden in women with recurrent ovarian cancer.
Gynecol Oncol
; 185: 128-137, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38412736
4.
Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancer.
Gynecol Oncol
; 183: 25-32, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38490057
5.
Quality of therapy in early ovarian cancer: results of the quality assurance program of the AGO Study Group.
Int J Gynecol Cancer
; 33(7): 1083-1089, 2023 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37001891
6.
Sensitivity and specificity of loss of heterozygosity analysis for the classification of rare germline variants in BRCA1/2: results of the observational AGO-TR1 study (NCT02222883).
J Med Genet
; 59(3): 248-252, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33273034
7.
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms.
N Engl J Med
; 380(9): 822-832, 2019 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30811909
8.
Adjuvant radiotherapy and local recurrence in vulvar cancer - a subset analysis of the AGO-CaRE-1 study.
Gynecol Oncol
; 164(1): 68-75, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34794839
9.
Measure of Ovarian Symptoms and Treatment concerns (MOST) indexes and their associations with health-related quality of life in recurrent ovarian cancer.
Gynecol Oncol
; 166(2): 254-262, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35718565
10.
Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study.
Int J Gynecol Cancer
; 32(6): 761-768, 2022 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35086926
11.
Role of Pelvic Lymph Node Resection in Vulvar Squamous Cell Cancer: A Subset Analysis of the AGO-CaRE-1 Study.
Ann Surg Oncol
; 28(11): 6696-6704, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33723714
12.
Age, treatment and prognosis of patients with squamous cell vulvar cancer (VSCC) - analysis of the AGO-CaRE-1 study.
Gynecol Oncol
; 161(2): 442-448, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33648748
13.
LION-PAW (lymphadenectomy in ovarian neoplasm) sexual function assessment: a prospective sub-study of the LION trial.
Int J Gynecol Cancer
; 30(10): 1548-1553, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32938723
14.
Association between obesity and vulvar cancer recurrence: an analysis of the AGO-CaRE-1 study.
Int J Gynecol Cancer
; 30(7): 920-926, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32467335
15.
Deleterious somatic variants in 473 consecutive individuals with ovarian cancer: results of the observational AGO-TR1 study (NCT02222883).
J Med Genet
; 56(9): 574-580, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30979843
16.
Early treatment modifications improve chemotherapy adherence in ovarian cancer patients ≥70â¯years.
Gynecol Oncol
; 153(3): 616-624, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30905433
17.
Predicting the course of disease in recurrent vulvar cancer - A subset analysis of the AGO-CaRE-1 study.
Gynecol Oncol
; 154(3): 571-576, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31324454
18.
Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study.
Gynecol Oncol
; 153(2): 286-291, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30760408
19.
Predictive factors for lymph node metastases in vulvar cancer. An analysis of the AGO-CaRE-1 multicenter study.
Gynecol Oncol
; 154(3): 565-570, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31227222
20.
TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33/AGO-OVAR OP7).
Int J Gynecol Cancer
; 29(8): 1327-1331, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31420412